Medtronic Expands ENT Portfolio with FDA Clearance of NIM Vital(TM) Next Generation Intraoperative Nerve Monitoring System and Acquisiton of Ai Biomed Corp.

New Technologies Address Most Common Challenges During Head and Neck Surgery DUBLIN, Oct. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food... Devices, Neurology, FDA, Mergers & Acquisitions Medtronic, Ai Biomed Corp, NIM Vital, nerve monitor, PTeye
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news